Table 1.
Clinical characteristics of patients with LCAS and patients with stroke alone.
| Variable | LCASG (n = 102) | SG (n = 102) | P value |
|---|---|---|---|
| Demographic variable | |||
| Age | 52.74 ± 10.49 | (51.21 ± 9.74) | <0.001a |
| Males | 84 (82.3%) | 84 (82.3%) | NSa |
| Females | 18 (17.6%) | 18 (17.6%) | NSa |
| Blood examination | |||
| RBC, ×1012/l | 4.20 ± 0.83 | 4.38 ± 0.62 | NSa |
| HGB, g/l | 120.24 ± 23.07 | 123.6 ± 18.5 | NSa |
| PLT, ×109/l | 207.8 ± 54.9 | 201.9 ± 67.4 | NSa |
| TT, s | 13.42 ± 2.22 | 13.11 ± 1.74 | NS |
| PT, s | 12.16 ± 1.53 | 11.75 ± 1.95 | NS a |
| APTT, s | 32.33 ± 3.82 | 32.24 ± 4.50 | NSa |
| INR | 1.04 ± 0.13 | 1.08 ± 0.61 | NSa |
| FIB, g/l | 4.81 ± 1.17 | 4.53 ± 0.93 | NSa |
| D-dimer, ng/ml | 478.1 ± 285.0 | 339.6 ± 256.9 | <0.001 |
| Multiple lesionsc | 55 (53.9%) | 8 (7.8%) | <0.001a |
| NHISS score | 8.86 ± 4.63 | 7.92 ± 3.68 | NSa |
| Prognosis at 30 days | |||
| NHISS score | 7.75 ± 5.62 | 4.47 ± 3.58 | <0.001a |
| mRS score | 2.79 ± 1.92 | 1.66 ± 1.22 | <0.001a |
| BI score | 65.2 ± 37.8 | 85.6 ± 22.2 | <0.001a |
| Death | 19 (18.63%) | 1 (0.98%) | <0.001b |
a = t-test, b = χ2 test
LCASG, lung cancer-associated stroke group; SG, stroke-alone group; HGB, hemoglobin; PLT, platelet; TT, thromboplastin time; PT, prothrombin time; APPT, activated partial thromboplastin time; FIB, fibrinogen NHISS, National Institutes of Health Stroke Scale, mRS, modified Rankin Scale; BI, Barthel Index.
NS, no statistically significant between-group differences (P ≥ 0.05).